Cargando…
FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer
SIMPLE SUMMARY: In the last decade, immunotherapy has revolutionized the treatment of malignant melanoma and non-small cell lung cancer. Even though both tumor types have the highest tumor mutational burden, a non-negligible portion of patients do not benefit from checkpoint inhibitor treatment. The...
Autores principales: | Grell, Peter, Borilova, Simona, Fabian, Pavel, Selingerova, Iveta, Novak, David, Muller, Petr, Kiss, Igor, Vyzula, Rostislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047850/ https://www.ncbi.nlm.nih.gov/pubmed/36980787 http://dx.doi.org/10.3390/cancers15061901 |
Ejemplares similares
-
PET/CT-tailored treatment of locally advanced oesophago-gastric
junction adenocarcinoma: a report on the feasibility of the multicenter
GastroPET study
por: Obermannova, Radka, et al.
Publicado: (2022) -
CXCL12 is associated with FoxP3(+) tumor-infiltrating lymphocytes and affects the survival of patients with oral squamous cell carcinoma
por: Zhang, Bowen, et al.
Publicado: (2019) -
Reinvigorating tumour-infiltrating lymphocytes from checkpoint inhibitor resistant melanomas
por: Silva, Inês Pires da, et al.
Publicado: (2018) -
Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
por: GRELL, PETER, et al.
Publicado: (2012) -
Increased CD3(+), CD8(+), or FoxP3(+) T Lymphocyte Infiltrations Are Associated with the Pathogenesis of Colorectal Cancer but Not with the Overall Survival of Patients
por: Barbosa, Ana Margarida, et al.
Publicado: (2021)